sophiris bio inc (SHS:Toronto)

Executive Profile*

Background*

Dr. Lars G. Ekman, M.D., Ph.D. serves as an Executive-in-Residence at Warburg Pincus LLC. Dr. Ekman is a Co-Founder of Cebix Incorporated and served as its Executive Chairman. He is an Executive Partner of Sofinnova Ventures Inc. He joined Sofinnova Venture Partners on September 19, 2008. He served as the President of Sophiris Bio, Inc. (formerly, Protox Therapeutics Inc). He served as Chief Executive Officer of Cebix Incorporated. He has more than 28 years in both senior ... executive, scientific, and clinical functions, as well as several clinical and academic positions in both the United States and Europe. He served as the Executive Vice President of Elan Corporation, plc (also known as Elan Pharmaceuticals Inc.) from 2001 to December 31, 2007 and served as its Head of the Neuro degeneration Business. He served as the President of Research and Development of Elan Corporation, plc from 2001 to June 2003 and served as its Unit President since 2001. He served as President of Global Research and Development and Corporate Strategy at Elan since June 2003 and served as its Advisor. He joined Elan in January 2001, and credited with advancing Elan's drug discovery pipeline during this period. Prior to joining Elan, he served as the Executive Vice President, Research and Development, at Schwarz Pharma AG since 1997. From 1984 to 1997, he has served in a variety of senior scientific and clinical functions at Pharmacia Corporation (now Pfizer). He has been an Executive Chairman at Sophiris Bio, Inc. since November 19, 2010 and Prothena plc since December 2012. He has been Chairman of the Board of Neotope Corporation Limited since 2012 and Director since May 2005. He serves as Executive Director of Cebix Incorporated. He serves as a Director of Ocera Therapeutics, Inc. and Cebix. He has been a Director at InterMune Inc. since September 21, 2006 and has been its Lead Independent Director since May 13, 2008. He has been a Director of Amarin Corporation plc since 2008 and also serves as its Lead Independent Director. He serves as a Member of Advisory Board at Columbine Ventures. He has been a Director of Sophiris Bio, Inc. since April 2011. He served as a Non-Executive Director of Elan Corporation, plc from May 26, 2005 to December 7, 2012. He served as an Independent Director of ARYx Therapeutics, Inc. from November 2003 to March 08, 2011. He served as a Director of Aderis Pharmaceuticals, Inc. He has held several clinical and academic positions in both the United States and Europe. Dr. Ekman is a board Certified Surgeon. He obtained a Ph.D. in Experimental Biology from the University of Gothenburg, Sweden. Dr. Ekman has an M.D from the University of Gothenburg, Sweden.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
SHS:CN	C$0.26 CAD	+0.005

COMPETITOR COMPENSATION